Sulphamidase is one of four lysosomal proteins whose deficiency clinically
manifests as Sanfilippo syndrome. Deficiency of sulphamidase results in the
lysosomal storage of the glycosaminoglycan (GAG) heparan sulphate (HS) and
is termed mucopolysaccharidosis type IIIA (MPS IIIA). Sulphamidase catalys
es the hydrolysis of an N-linked sulphate from the nonreducing terminal glu
cosaminide residue of HS (Fig. 1). It is unique among the known lysosomal s
ulphatases involved in GAG degradation in that it is an N-sulphatase, all t
he others being O-sulphatases. Purification of sulphamidase from human live
r has facilitated the amino-terminal sequencing of the protein and hence th
e isolation of cDNA and genomic clones for sulphamidase. This has in turn m
ade possible a range of further studies aimed at better diagnosis, treatmen
t and understanding of MPS IIIA. (C) 1999 Elsevier Science Ltd. All rights
reserved.